Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
AssigneeThe Trustees of Indiana University
InventorsJaipal Singh, Kerry Fowler
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds that can modulate DDAH and the amount of asymmetric dimethylarginine (ADMA) in a subject. Also provided are pharmaceutical compositions comprising these compounds, as well as methods of using these compositions to treat and/or prevent diseases associated with elevated or low levels of DDAH and ADMA.
Claims20
A method for modulating DDAH and asymmetric dimethylarginine (ADMA) in a subject, the method comprising administering to the subject a composition comprising a therapeutically effective amount of a compound defined by Formula I:
- or a pharmaceutically acceptable salt or prodrug thereof, wherein
- represents a single, double, or triple bond;
- X1 and X2, as valence permits, are independently absent with one of X1 and X2, being selected from C, CH, CH2, O, CO, S, SO2, and NR′ or both X1 and X2, as valence permits, are independently selected from C, CH, CH2, O, CO, S, SO2, and NR′;
- wherein R′ is independently selected from hydrogen or C1-C6 alkyl;
- or X1 and X2 together with the bond to which they are attached form a 3 or 4 membered carbocyclic ring;
- R2 is, independently for each occurrence, selected from halogen, cyano, hydroxyl, amino, alkylamino, dialkylamino, alkyl, haloalkyl;
- alkylthio;
- haloalkylthio;
- alkoxy, haloalkoxy, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, alkylcarbonyl, haloalkylcarbonyl, alkoxy carbonyl, haloalkoxy carbonyl, alkylaminocarbonyl, heteroalkylaminocarbonyl, dialkylaminocarbonyl, and heterodialkylaminocarbonyl;
- n is an integer from 0 to 4;
- Y is selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl, each optionally substituted with one or more substituents individually selected from R″;
- and
- R″ is, independently for each occurrence, selected from fluoro, cyano, nitro, hydroxyl, amino, alkylamino, dialkylamino, nitrile, alkyl, haloalkyl;
- alkylthio;
- haloalkylthio;
- alkoxy, haloalkoxy, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, alkylcarbonyl, haloalkylcarbonyl, alkoxy carbonyl, haloalkoxy carbonyl, alkylaminocarbonyl, heteroalkylaminocarbonyl, dialkylaminocarbonyl, and heterodialkylaminocarbonyl, with the proviso that when R″ is hydroxyl, Y further comprises a second substituent.
A compound defined by the general structure:
- or a pharmaceutically acceptable salt or prodrug thereof, wherein
- is a single, double, or triple bond;
- X1 and X2 as valence permits, are independently absent, with one of X1 and X2, being selected from C, CH, C2, O, CO, S, SO2, and NR′ or both X1and X2, as valence permits, are independently selected from C, CH, CH2, O, CO, S, SO2, and NR′;
- wherein R is independently selected from hydrogen or C1-C6 alkyl;
- or X1 and X2 together with the bond to which they are attached form a 3 or 4 membered carbocyclic ring.
Dependencies are inferred from the claim text.